Obsidian Therapeutics, Inc. (OBX)
Obsidian Therapeutics, Inc. (OBX)
| Cash Flow | 2026-06-30 |
|---|---|
| Net loss | 0 |
| Changes in operating assets and liabilities | 0 |
| Net cash used in operating activities | 0 |
| Net cash provided by investing activities | 0 |
| Net cash provided by financing activities | 0 |
| Net decrease in cash and cash equivalents and restricted cash | 0 |
| Cash at end of period | 0 |